Research-grade hCG is used to study Leydig cell steroidogenesis, LHCGR receptor pharmacology and biased agonism, corpus luteum and reproductive biology, and endoplasmic-reticulum stress responses in steroidogenic cells
[7] All potential female patients are screened and counseled on this point, and effective contraception is recommended for those undergoing NAD+ therapy if applicable
What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect
Retatrutide vs Tirzepatide Compare triple vs dual agonist.
Reconstituted BPC-157 (mixed with bacteriostatic water for injection) becomes thermally labile the moment water reintroduces hydrolytic pathways that break peptide bonds
More than 100 published studies have evaluated the compound in in-vitro and animal model systems, including gastrointestinal cytoprotection models, tendon and ligament tissue research, and neurological signaling pathway investigations